tiprankstipranks
Trending News
More News >

Mega Genomics Faces Delay in 2024 Results Publication Amid Audit Issues

Story Highlights
Mega Genomics Faces Delay in 2024 Results Publication Amid Audit Issues

Don’t Miss TipRanks’ Half-Year Sale

Mega Genomics Limited ( (HK:6667) ) has provided an update.

Mega Genomics Limited has announced a delay in the publication of its 2024 Annual Results due to unresolved issues related to revenue recognition from genetic testing kits and promotional activities. The company is working with its auditor to verify the rationale behind these transactions and may engage external parties for further investigation. An investigation committee has been established to address these issues, but the timeline and costs for the additional audit work are yet to be determined. Trading of the company’s stock remains suspended.

More about Mega Genomics Limited

YTD Price Performance: -34.43%

Average Trading Volume: 111,572

Technical Sentiment Signal: Buy

Current Market Cap: HK$1.61B

See more data about 6667 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1